CORC

在结果中检索

CORC

浏览/检索结果: 共172条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after curative hepatic resection or ablation: EMERALD-2 会议论文
作者:  Knox, J.;  Cheng, A.;  Cleary, S.;  Galle, P.;  Kokudo, N.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
IG-IMRT improves short-term survival for lymph node metastases from hepatocellular carcinoma 会议论文
作者:  Haige, Z.;  Jing, S.;  Yixing, C.;  Zhaochong, Z.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Value of F-18-FDG PET/CTin the diagnosis of portal vein tumor thrombus in patients with hepatocellular carcinoma 会议论文
作者:  Wu, Bing
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Efficacy, safety, and pharmacokinetics of the anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, tislelizumab (BGB-A317) in a phase 2, open-label, multicenter study to investigate in patients with unresectable hepatocellular carcinoma - Trial in progress 会议论文
作者:  Ren, Z.;  Assenat, E.;  Cubillo, A.;  Pluntke, S.;  Rimassa, L.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Differences in presentation and management patterns in patients with hepatocellular carcinoma (HCC) between China and Singapore: Initial data from the HCC Registry in Asia. 会议论文
作者:  Chow, Pierce K. H.;  Li, Lequn;  Li, Jiangtao;  Tan, Poh-Seng;  Jia, Fan
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Large-Scale Prediction of a-to-I RNA Editing Events in Human Hepatocellular Carcinoma 会议论文
作者:  Song, Guangqi;  Zhao, Yicheng;  Zhu, Ji-Min;  Shen, Xi-Zhong
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Direct Activation of MAP3K2 By microRNA-93-5p Promotes Proliferation of Hepatocellular Carcinoma 会议论文
作者:  Shi, Xuan;  Zhu, Ji-Min;  Yu, Xiang-Nan;  Bilegsaikhan, Enkhnaran;  Song, Guangqi
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
O-GLCNACYLATION ON RAB3A ATTENUATES ITS EFFECTS ON MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION AND METASTASIS IN HEPATOCELLULAR CARCINOMA 会议论文
作者:  Wang Yilin;  Wu Weicheng
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Phase II trial of tepotinib vs sorafenib for treatment-naive advanced hepatocellular carcinoma (HCC) in Asian patients 会议论文
作者:  Ryoo, B-Y.;  Ren, Z.;  Kim, T-Y.;  Pan, H.;  Rau, K-M.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
The characteristics of non-alcoholic fatty liver disease related hepatocellular carcinoma in a Chinese population: a retrospective study 会议论文
作者:  Chen, H.;  Li, X.;  Gao, X.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace